Cellular Biomedicine Group Inc. , a biomedicine firm engaged in the development of effective stem cell therapies for degenerative diseases and immunotherapies for cancer, today announced that an interview with Dr. William Cao, Chief Executive Officer for the Company, conducted by Stock News Now at last month's J.P. Morgan Healthcare Conference in San Francisco, is now available online. The interview provides an overview of the Company's immune cell therapy platform focused on oncology and its Phase II clinical trial for Knee Osteoarthritis , which is differentiated by its use of the patient's own fat tissue.
http://ift.tt/16o10VV
http://ift.tt/16o10VV
No comments:
Post a Comment